These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 553807)

  • 1. Prevention of the mutagenic activation of an antischistosomal isothiocyanate in primates by an antibiotic.
    Batzinger RP; Bueding E; Crawford K; Bruce J
    Environ Mutagen; 1979; 1(4):353-60. PubMed ID: 553807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo.
    Molineaux CJ; Batzinger RP; Schmidt W; Bueding E
    Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amoscanate against experimental schistosomal infections in monkeys.
    Crawford KA; Asch HL; Bruce JI; Bueding E; Smith ER
    Am J Trop Med Hyg; 1983 Sep; 32(5):1055-64. PubMed ID: 6625061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of amoscanate to a mutagenic metabolite in gnotobiotic mice implanted with Streptococcus equinus.
    Reddy BS; Batzinger RP; Molineaux CJ; Bueding E
    Antimicrob Agents Chemother; 1982 Oct; 22(4):707-8. PubMed ID: 7181482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to a schistosomacide, amoscanate. I. Serum antibody responses.
    Barton BE; Levy DA
    J Immunopharmacol; 1985; 7(3):343-71. PubMed ID: 2414366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by antibiotics against experimental focal cholangitis produced in mice by a schistosomicidal isothiocyanate.
    Batzinger RP; Bueding E; Popper H
    Hepatology; 1981; 1(1):21-7. PubMed ID: 7286888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schistosoma mansoni: tegumental surface alterations induced by subcurative doses of the schistosomicide amoscanate.
    Voge M; Bueding E
    Exp Parasitol; 1980 Oct; 50(2):251-9. PubMed ID: 7409075
    [No Abstract]   [Full Text] [Related]  

  • 8. Formation of a mutagenic drug metabolite by intestinal microorganisms.
    Batzinger RP; Bueding E; Reddy BS; Weisburger JH
    Cancer Res; 1978 Mar; 38(3):608-12. PubMed ID: 414832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antischistosomal and some toxicological properties of a nitrodiphenylaminoisothiocyanate (C 9333-Go/CGP 4540).
    Bueding E; Batzinger R; Petterson G
    Experientia; 1976 May; 32(5):604-6. PubMed ID: 1278309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electron microscopic studies on the effect of nithiocyamine on Schistosoma japonica].
    Yu HZ; Lu M; Zhao KB; Wang P
    Yao Xue Xue Bao; 1983 Mar; 18(3):169-73. PubMed ID: 6880755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radioimmunoassay for an antischistosomal drug, 4-nitro-4'-isothiocyano-diphenylamine (7505) (author's transl)].
    Wang ZT; Wang DN; Li Q; Ouyang HJ
    Yao Xue Xue Bao; 1980 Aug; 15(8):463-9. PubMed ID: 7211390
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological changes elicited in Schistosoma japonicum infected rabbits following curative chemotherapy with 4-isothiocyano-4'-nitro-diphenylamine (C9333-Go/CGP 4540).
    Robinson A; Lewert RM
    Trans R Soc Trop Med Hyg; 1981; 75(3):415-7. PubMed ID: 7324109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of the hepatic drug-metabolizing capacity in mice infected with Schistosoma mansoni following curative chemotherapy with the schistosomicide 4-isothiocyano-4'-nitro-diphenylamine (CGP 4540).
    Cha YN; Bueding E
    Am J Trop Med Hyg; 1978 Nov; 27(6):1188-91. PubMed ID: 727323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experimental therapy and mechanism of action of nithiocyamine on Schistosoma japonica].
    Yu HZ
    Yao Xue Xue Bao; 1981 Sep; 16(9):641-7. PubMed ID: 7331811
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies on the elimination of nithiocyamine from patients with schistosomiasis and its toxicities to the liver-bile system of rats].
    Liu CX; Huang WT; Liu RF; Ye GZ; Xiang JJ; Zhang ZL; Hu JC
    Yao Xue Xue Bao; 1983 Feb; 18(2):86-9. PubMed ID: 6613597
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological alterations of Schistosoma japonicum associated with the administration of amoscanate.
    Irie Y; Yasuraoka K
    Jpn J Exp Med; 1982 Jun; 52(3):139-48. PubMed ID: 7131858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the effect of Amoscanate on the immature stages of S. mansoni and S. haematobium worms in hamsters.
    Khalil SB; Girgis NI; Mansour NS
    J Egypt Soc Parasitol; 1986 Dec; 16(2):699-706. PubMed ID: 3097173
    [No Abstract]   [Full Text] [Related]  

  • 18. Schistosoma haematobium: amoscanate and adult worm ultrastructure.
    Leitch B; Probert AJ
    Exp Parasitol; 1984 Dec; 58(3):278-89. PubMed ID: 6500001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antischistosomal effects of cyclosporin A.
    Bueding E; Hawkins J; Cha YN
    Agents Actions; 1981 Jul; 11(4):380-3. PubMed ID: 7282489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in antischistosomal and mutagenic properties between an isothiocyano- and an isocyanonitrodiphenylamine.
    Coulter AW; Bueding E; Batzinger RP
    J Med Chem; 1977 Jul; 20(7):981-2. PubMed ID: 327069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.